Stability study of sodium iodide (123 I) oral solution


  • Tanira Giara Mello a:1:{s:5:"pt_BR";s:31:"Instituto de Engenharia Nuclear";}
  • Erica de Araujo Lima Andrade
  • Marcilene Aparecida Silva Carmo
  • Cintia A. Custódio Instituto de Engenharia Nuclear
  • Cláudio Reis Sant'anna
  • Rosilene Fiuza Silva
  • Gonçalo Rodrigues Santos
  • Luiz Cláudio Martins Aleixo
  • Julio Cezar Suita


Sodium iodide (123 I) produced by the Nuclear Engineering Institute (IEN) is an oral  radiopharmaceutical with a half-life of 13.2 h. It is stored at room temperature (15 - 30 ° C) and its activity is calibrated for the hospital to use the next day. The objective of this work was to evaluate the stability following ANVISA recommendations and determine your shelf life. It is concluded that all criteria for acceptance of quality requirements were met in the period of 48 h.




Como Citar

Mello, T. G., Andrade, E. de A. L., Carmo, M. A. S., A. Custódio , C. ., Sant’anna, C. R., Silva, R. F., … Suita, J. C. (2021). Stability study of sodium iodide (123 I) oral solution . Instituto De Engenharia Nuclear: Progress Report, (4). Recuperado de



Radiopharmaceuticals Production